|
RNF160 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.168100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.763000E-01 |
| Normal-vs-Stage2 |
9.409200E-01 |
| Normal-vs-Stage3 |
3.528100E-02 |
| Normal-vs-Stage4 |
1.544110E-03 |
| Stage1-vs-Stage2 |
6.625600E-01 |
| Stage1-vs-Stage3 |
7.060200E-02 |
| Stage1-vs-Stage4 |
4.464800E-03 |
| Stage2-vs-Stage3 |
1.279160E-01 |
| Stage2-vs-Stage4 |
2.664500E-02 |
| Stage3-vs-Stage4 |
2.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.564190E-01 |
| Normal-vs-AfricanAmerican |
6.140600E-03 |
| Normal-vs-Asian |
9.948400E-01 |
| Caucasian-vs-AfricanAmerican |
7.521600E-02 |
| Caucasian-vs-Asian |
6.881400E-01 |
| AfricanAmerican-vs-Asian |
2.120600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.624000E-02 |
| Normal-vs-Female |
2.763200E-01 |
| Male-vs-Female |
4.407400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.664000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.301200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.239900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.809000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.633400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.091000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.390960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.214600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.146800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.026400E-01 |
| Normal-vs-Grade 2 |
9.697400E-01 |
| Normal-vs-Grade 3 |
2.404100E-02 |
| Normal-vs-Grade 4 |
9.94970000000039E-05 |
| Grade 1-vs-Grade 2 |
4.318400E-01 |
| Grade 1-vs-Grade 3 |
3.465800E-02 |
| Grade 1-vs-Grade 4 |
1.898600E-03 |
| Grade 2-vs-Grade 3 |
7.915200E-03 |
| Grade 2-vs-Grade 4 |
2.13799999999598E-05 |
| Grade 3-vs-Grade 4 |
1.795700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.401400E-01 |
| Normal-vs-ccB subtype |
3.320200E-02 |
| ccA subtype-vs-ccB subtype |
1.061770E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.508600E-01 |
| Normal-vs-N1 |
9.250000E-02 |
| N0-vs-N1 |
3.235200E-01 |
|
|
